NanoCell Therapeutics, Inc.

Non-viral DNA-based in vivo gene therapy platform, transforming adoptive cell therapy into in vivo gene therapy. We primarily develop in vivo CAR-TCR therapies, using proprietary cell-directed lipid nanoparticles for delivery of stably integrating DNA, to provide durable efficacy.

Address

Wayne
PA
United States

Website

https://www.nanocelltx.com

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS